Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
- PMID: 2939312
- DOI: 10.1016/0024-3205(86)90137-2
Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
Abstract
The disappearance and metabolic clearance rate (MCR) of alpha human atrial natriuretic peptide (alpha h-ANP) has been studied in normal man by radioimmunoassay of the atrial peptide in plasma and plasma extracts. After an intravenous (iv) bolus injection of 100 micrograms alpha h-ANP, levels of immunoreactive alpha h-ANP (IR-alpha hANP) in unextracted plasma fell rapidly and exponentially during the first 10 min (t1/2 = 2.5 min), after which levels declined more slowly to reach basal values 30 min after injection. Venous plasma extracts, purified by Sep Pak cartridges, were used to calculate the MCR of IR-alpha hANP under steady state conditions of constant iv infusion (200 micrograms over 60 min) in healthy volunteers. Calculated MCR from venous samples was 2.4 L/min and volume of distribution 10.7 L. After cessation of infusions, the disappearance rate (rapid phase) of IR-alpha hANP was 3.1 min. These studies show that alpha h-ANP is rapidly metabolized at rates similar to other vasoactive hormones such as angiotensin II and vasopressin.
Similar articles
-
Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.J Clin Endocrinol Metab. 1986 Oct;63(4):946-53. doi: 10.1210/jcem-63-4-946. J Clin Endocrinol Metab. 1986. PMID: 2943757
-
Renal disposal of human atrial natriuretic peptide in man.Metabolism. 1990 Apr;39(4):341-2. doi: 10.1016/0026-0495(90)90246-9. Metabolism. 1990. PMID: 2139158
-
Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma.J Clin Endocrinol Metab. 1986 Jul;63(1):72-9. doi: 10.1210/jcem-63-1-72. J Clin Endocrinol Metab. 1986. PMID: 2940257
-
Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.Endocrinology. 1992 Feb;130(2):755-65. doi: 10.1210/endo.130.2.1531129. Endocrinology. 1992. PMID: 1531129
-
Atrial natriuretic peptide in human hypertension.Eur Heart J. 1987 May;8 Suppl B:123-8. doi: 10.1093/eurheartj/8.suppl_b.123. Eur Heart J. 1987. PMID: 2956107 Review.
Cited by
-
Kinetics of atrial natriuretic peptide in young and elderly subjects.Eur J Clin Pharmacol. 1992;42(4):449-52. doi: 10.1007/BF00280134. Eur J Clin Pharmacol. 1992. PMID: 1387608
-
Pharmacokinetics and effects of atrial natriuretic factor during hypothermic cardiopulmonary bypass.Eur J Clin Pharmacol. 1992;43(6):647-50. doi: 10.1007/BF02284966. Eur J Clin Pharmacol. 1992. PMID: 1493848
-
Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice.J Neurosci. 2013 Feb 6;33(6):2457-64. doi: 10.1523/JNEUROSCI.3407-12.2013. J Neurosci. 2013. PMID: 23392674 Free PMC article.
-
Atrial natriuretic peptides: clues to their physiological and clinical importance.Postgrad Med J. 1987 Jan;63(735):1-4. doi: 10.1136/pgmj.63.735.1. Postgrad Med J. 1987. PMID: 2959912 Free PMC article. Review. No abstract available.
-
Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site.Biochem J. 1988 Sep 1;254(2):531-7. doi: 10.1042/bj2540531. Biochem J. 1988. PMID: 2972276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources